Advances in the Research and Application of Exosomes in Disease Detection and Diagnosis
Exosomes are vesicles secreted by cells that are widely present in various bodily fluids such as blood, urine, saliva, milk, and have a particle size ranging from 30 to 150 nanometers.
September 3, 2025
by Xiaonisha
Six Proteins Upregulated Years Before Ulcerative Colitis Diagnosis
Six inflammatory proteins are upregulated in plasma several years before diagnosis of ulcerative colitis, according to a report published in the November issue of Gastroenterology.
November 25, 2021
by Drugs
GTP Bioways to galvanise CDMO position in France with two new biopharma facilities
The specialist biotherapies and nanotherapies producer has said the first line, which will have a capacity of 300 L, will focus on production using microbial systems (bacteria and yeast), and will be operational in early 2023.
October 29, 2021
by CPhIonline
Study reveals how coronavirus could hijack human cells
Scientists, including one of Indian-origin, have identified parts of human proteins which thehuman proteins could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19.
February 18, 2021
by expresspharma
How SARS-CoV-2 interacts with cells
SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the virus and the cells it infects.
December 23, 2020
by worldpharmanews
Existing drugs can prevent SARS-CoV-2 from hijacking cells
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells.
June 30, 2020
by worldpharmanews
Pfenex, Arcellx Announce Development, Evaluation and License Agreement
Arcellx gains access to Pfenex Expression Technology® platform to advance multiple proprietary sparX proteins.
August 2, 2019
by contractpharma
Relay Therapeutics bags $400M to ramp up discovery and push into the clinic
Two weeks after expanding its R&D team, Relay Therapeutics is reeling in a massive $400 million series C round to boost its platform technology and discovery efforts, build its pipeline and get into the clinic......
December 25, 2018
by fiercebiotech
Novo begins R&D tie-up with AI biotech e-Therapeutics
Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.
December 13, 2018
by pharmaphorum
2 proteins show promise as targets for treating obesity
The human body has intricate methods for regulating fat storage and maintaining weight. But sometimes those mechanisms fail to work properly, particularly in the context of a high-fat diet, or they actually counteract attempts to lose weight.
August 23, 2018
by fiercebiotech
AGC Biologics Expands Capacity at Berkeley, California Facility
AGC Biologics, announced today that their Berkeley, California facility is adding to its growing capacity with the addition of a 2000L single-use bioreactor (SUB).
March 7, 2018
by prnasia
SGS Expands Bioanalytical Services at Poitiers Lab
Invests in multiple highly sensitive and selective LC-MS/MS instruments
March 21, 2017
by financialexpress